The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes

被引:120
作者
Hoffmann, C
Moro, S
Nicholas, RA
Harden, TK
Jacobson, KA
机构
[1] NIDDK, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.274.21.14639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The P2Y(1) receptor is a membrane-bound G protein-coupled receptor stimulated by adenine nucleotides, Using alanine scanning mutagenesis, the role in receptor activation of charged amino acids (Asp, Glu, Lys, and Arg) and cysteines in the extracellular loops (EL) of the human P2Y(1) receptor has been investigated. The mutant receptors were expressed in COS-7 cells and measured for stimulation of phospholipase C induced by the potent agonist 2-methylthioadenosine-5'-diphosphate (2-MeSADP), In addition to single point mutations, all receptors carried the hemagglutinin epitope at the N-terminus for detection of cell-surface expression. The C124A and C202A mutations, located near the exofacial end of transmembrane helix 3 and in EL2, respectively, ablated phospholipase C stimulation by less than or equal to 100 mu M 2-MeSADP, Surface enzyme-linked immunosorbent assay detection of both mutant receptors showed <10% expression, suggesting that a critical disulfide bridge between EL2 and the upper part of transmembrane 3, as found in many other G protein coupled receptors, is required for proper trafficking of the P2Y(1) receptor to the cell surface. In contrast, the C42A and C296A mutant receptors (located in the N-terminal domain and EL3) were activated by 2-MeSADP, but the EC50 values were > 1000-fold greater than for the wild-type receptor. The double mutant receptor C42A/C296A exhibited no additive shift in the concentration-response curve for 2-MeSADP, These data suggest that Cys(42) and Cys(296) form another disulfide bridge in the extracellular region, which is critical for activation. Replacement of charged amino acids produced only minor changes in receptor activation, with two remarkable exceptions. The E209A mutant receptor (EL2) exhibited a >1000-fold shift in EC,,, However, if Glu(209) were substituted with amino acids capable of hydrogen bonding (Asp, Gin, or Arg), the mutant receptors responded like the wild-type receptor. Arg(287) in EL3 was impaired similarly to Glu(209) when substituted by alanine. Substitution of Arg287 by lysine, another positively charged residue, failed to fully restore wild-type activity.
引用
收藏
页码:14639 / 14647
页数:9
相关论文
共 47 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]  
AKENSON M, 1997, J BIOL CHEM, V272, P17405
[3]  
[Anonymous], [No title captured]
[4]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[5]   Modes of peptide binding in G protein-coupled receptors [J].
Berthold, M ;
Bartfai, T .
NEUROCHEMICAL RESEARCH, 1997, 22 (08) :1023-1031
[6]   The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: Presence of a disulfide bond [J].
Boyd, ND ;
Kage, R ;
Dumas, JJ ;
Krause, JE ;
Leeman, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :433-437
[7]   Identification of potent P-2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate [J].
Boyer, JL ;
Siddiqi, S ;
Fischer, B ;
RomeroAvila, T ;
Jacobson, KA ;
Harden, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :1959-1964
[8]  
Burnstock G, 1996, DRUG DEVELOP RES, V38, P67, DOI 10.1002/(SICI)1098-2299(199605)38:1<67::AID-DDR9>3.0.CO
[9]  
2-J
[10]   Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors [J].
Camaioni, E ;
Boyer, JL ;
Mohanram, A ;
Harden, TK ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :183-190